Cargando…
Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971405/ https://www.ncbi.nlm.nih.gov/pubmed/24671946 http://dx.doi.org/10.1098/rsob.130172 |
_version_ | 1782309470603313152 |
---|---|
author | Franke, Barbara Gasch, Alexander Rodriguez, Dayté Chami, Mohamed Khan, Muzamil M. Rudolf, Rüdiger Bibby, Jaclyn Hanashima, Akira Bogomolovas, Julijus von Castelmur, Eleonore Rigden, Daniel J. Uson, Isabel Labeit, Siegfried Mayans, Olga |
author_facet | Franke, Barbara Gasch, Alexander Rodriguez, Dayté Chami, Mohamed Khan, Muzamil M. Rudolf, Rüdiger Bibby, Jaclyn Hanashima, Akira Bogomolovas, Julijus von Castelmur, Eleonore Rigden, Daniel J. Uson, Isabel Labeit, Siegfried Mayans, Olga |
author_sort | Franke, Barbara |
collection | PubMed |
description | MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fold as well as for high-order assembly into functional entities. But data on CC from this family that can clarify the structural significance of this motif are scarce. We have characterized the helical region from MuRF1 and show that, contrary to expectations, its CC domain assembles unproductively, being the B2- and COS-boxes in the fold (respectively flanking the CC) that promote a native quaternary structure. In particular, the C-terminal COS-box seemingly forms an α-hairpin that packs against the CC, influencing its dimerization. This shows that a C-terminal variable domain can be tightly integrated within the conserved TRIM fold to modulate its structure and function. Furthermore, data from transfected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of sarcoskeletal structures and points to the pharmacological relevance of the COS domain for treating MuRF1-mediated muscle atrophy. |
format | Online Article Text |
id | pubmed-3971405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-39714052014-04-16 Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 Franke, Barbara Gasch, Alexander Rodriguez, Dayté Chami, Mohamed Khan, Muzamil M. Rudolf, Rüdiger Bibby, Jaclyn Hanashima, Akira Bogomolovas, Julijus von Castelmur, Eleonore Rigden, Daniel J. Uson, Isabel Labeit, Siegfried Mayans, Olga Open Biol Research MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fold as well as for high-order assembly into functional entities. But data on CC from this family that can clarify the structural significance of this motif are scarce. We have characterized the helical region from MuRF1 and show that, contrary to expectations, its CC domain assembles unproductively, being the B2- and COS-boxes in the fold (respectively flanking the CC) that promote a native quaternary structure. In particular, the C-terminal COS-box seemingly forms an α-hairpin that packs against the CC, influencing its dimerization. This shows that a C-terminal variable domain can be tightly integrated within the conserved TRIM fold to modulate its structure and function. Furthermore, data from transfected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of sarcoskeletal structures and points to the pharmacological relevance of the COS domain for treating MuRF1-mediated muscle atrophy. The Royal Society 2014-03-26 /pmc/articles/PMC3971405/ /pubmed/24671946 http://dx.doi.org/10.1098/rsob.130172 Text en http://creativecommons.org/licenses/by/3.0/ © 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Research Franke, Barbara Gasch, Alexander Rodriguez, Dayté Chami, Mohamed Khan, Muzamil M. Rudolf, Rüdiger Bibby, Jaclyn Hanashima, Akira Bogomolovas, Julijus von Castelmur, Eleonore Rigden, Daniel J. Uson, Isabel Labeit, Siegfried Mayans, Olga Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title | Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title_full | Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title_fullStr | Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title_full_unstemmed | Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title_short | Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 |
title_sort | molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin murf1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971405/ https://www.ncbi.nlm.nih.gov/pubmed/24671946 http://dx.doi.org/10.1098/rsob.130172 |
work_keys_str_mv | AT frankebarbara molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT gaschalexander molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT rodriguezdayte molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT chamimohamed molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT khanmuzamilm molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT rudolfrudiger molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT bibbyjaclyn molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT hanashimaakira molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT bogomolovasjulijus molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT voncastelmureleonore molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT rigdendanielj molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT usonisabel molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT labeitsiegfried molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 AT mayansolga molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1 |